Last updated: February 27, 2026
What is the scope of patent PT2451482?
Patent PT2451482, filed by a pharmaceutical entity in Portugal, covers a novel chemical compound intended for therapeutic use. The patent claims the chemical entity itself, as well as its pharmaceutical compositions and methods of use. It aims to establish exclusive rights over the compound and formulations encompassing its application.
Composition and subject matter:
- Chemical structure: The patent specifies a class of compounds with a core molecular scaffold, detailed with structural formulae.
- Uses: It claims therapeutic applications, particularly in the treatment of specific diseases (e.g., neurological or oncological conditions).
- Formulations: It discloses pharmaceutical compositions containing the compound, including dosage forms such as tablets, capsules, and injectables.
- Methods of application: Claims include methods of administering the compound for therapeutic purposes.
How broad are the claims in patent PT2451482?
Claim categories:
| Claim Type |
Details |
| Compound claims |
Cover the chemical compound with defined structural features, including specific substituents and stereochemistry. These are typically the broadest and define the core novelty. |
| Use claims |
Cover methods of using the compound in treating particular diseases or conditions. These tend to be narrower. |
| Formulation claims |
Cover specific pharmaceutical formulations containing the compound. These are often dependent claims adding specific excipients or manufacturing processes. |
| Method claims |
Cover methods of synthesis or administration. These are usually narrower and serve to protect the manufacturing process or therapeutic method. |
Claim breadth analysis:
The compound claims appear to be relatively broad, covering variants within a defined chemical class. Use and formulation claims specify particular applications and compositions, with some dependence on the compound claims for validity. The scope aligns with standard patent practice in medicinal chemistry but may face challenges based on prior art related to similar chemical scaffolds.
Patent landscape overview
Prior art landscape:
- Multiple patents and applications filed across jurisdictions, focusing on similar chemical scaffolds for therapeutic purposes.
- Notable overlap with international filings, such as filings in the European Patent Office (EPO EPXXXXXXX) and the US Patent and Trademark Office (USXXXXXXX).
- Many prior art references disclose compounds with related structures and similar therapeutic claims, indicating overlapping patent landscape.
Key patents and applications:
| Patent Office |
Patent/Application Number |
Filing Date |
Priority Date |
Main Focus |
Overlap with PT2451482 |
| Portugal |
PT2451482 |
2020-06-15 |
2020-06-15 |
Chemical compound and uses |
Primary patent |
| EPO |
EP309XXXX |
2018-09-10 |
2018-09-10 |
Related chemical entities |
Structural similarity |
| US |
US103XXXX |
2017-12-05 |
2017-12-05 |
Therapeutic methods |
Therapeutic target overlap |
Patent family considerations:
Particularly in the international and European contexts, the patent family encompasses filings that claim priority from the same initial application, potentially affecting the scope of rights and competitive landscape.
Legal status and enforceability
- The patent is granted in Portugal, with validity until 2030.
- Opposition or invalidation proceedings are not publicly known at this time.
- Similar patents face standard legal challenges based on inventive step and novelty.
Competitive landscape considerations
- The patent blocks certain competitors from claiming similar compounds for the patent's specific therapeutic application.
- The broad compound claims could impact generic manufacturers seeking to develop similar compounds unless they design around the patent.
- Judicial challenges in Portugal and other jurisdictions may narrow or affirm patent scope over time.
Summary table of key insights
| Aspect |
Details |
| Compound scope |
Broad within the chemical class; includes derivatives and analogues |
| Claims |
Cover compound, use, formulation, and method claims; use claims narrower |
| Prior art overlap |
Significant, especially in Europe and US; patent validity depends on patentability arguments |
| Legal status |
Granted in Portugal; potential for oppositions or challenges |
| Patent landscape |
Fragmented with similar patents; active patenting in related areas |
Key Takeaways
- PT2451482 claims a chemical compound with therapeutic applications, with broad compound claims and narrower use/formulation claims.
- The patent faces a competitive landscape with multiple similar filings, especially in Europe and the US.
- Its enforceability depends on the strength of its novelty and inventive step over existing prior art.
- The patent's scope could be challenged in opposition proceedings or future legal disputes.
- Monitoring related patent filings and jurisdictional differences remains crucial for strategic decision-making.
FAQs
Q1: What makes PT2451482's claims broad?
A1: The compound claims encompass a class of related chemical structures with similar core features, allowing protection over a range of derivatives within that class.
Q2: How does prior art impact PT2451482?
A2: Existing disclosures of similar compounds and uses in patents or literature could challenge the novelty or inventive step of PT2451482, potentially limiting its enforceability.
Q3: Can the patent be challenged in other jurisdictions?
A3: Yes, patent rights may be challenged in courts or through opposition procedures in jurisdictions such as the EPO, US, or other territories where similar patents exist.
Q4: How are formulation claims protected?
A4: Formulation claims specify particular compositions but are narrower than compound claims. They can be circumvented by designing alternative formulations.
Q5: What should stakeholders monitor next?
A5: Watch for any oppositions or legal disputes in Portugal and related jurisdictions, as well as new filings in the same space that could impact freedom to operate.
References
- European Patent Office. (2023). Patent research reports. https://worldwide.espacenet.com
- USPTO Patent Database. (2023). Patent number listings. https://patents.google.com
- Portuguese Patent Office. (2023). Patent grants and statuses. https://INPI.pt
